Table 1.
Demographic and Clinical Characteristics (n=15)
| Mean | SD | |
|---|---|---|
| Age (Years) | 46.7 | 10.4 |
| Length of Illness (Years) | 30.6 | 11.2 |
| Length of Current Episode (Months) | 20.9 | 27.5 |
| Psychotropic Medications at Admission | 3.7 | 1.5 |
| Length of Therapeutic Mood Stabilizer Prior to Randomization (Days) | 63.3 | 98.7 |
| Lifetime Antidepressant Trials | 9.7 | 4.3 |
| N | % | |
| Sex (Female) | 8 | 53 |
| Education | ||
| • College/Graduate School | 5 | 33 |
| • Incomplete College | 9 | 60 |
| • High School | 1 | 7 |
| Disability | 8 | 53 |
| Unemployed | 12 | 80 |
| Family History | ||
| • Mood Disorder | 13 | 87 |
| • Alcohol Abuse or Dependence | 11 | 73 |
| Life History | ||
| • Suicide Attempt | 6 | 40 |
| • Sexual Abuse | 2 | 13 |
| Lifetime Diagnosis | ||
| • Alcohol Abuse or Dependence | 9 | 60 |
| • Substance Abuse or Dependence | 6 | 40 |
| • Anxiety Disorder | 11 | 73 |
| • Psychosis | 5 | 33 |
| Bipolar subtype | ||
| • I | 9 | 60 |
| • II | 6 | 40 |
| Rapid cycling | ||
| • Past 12 months | 0 | 0 |
| • Lifetime | 9 | 60 |
| Mood Stabilizer | ||
| • Lithium | 11 | 73 |
| • Valproate | 4 | 27 |